XML 23 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Cash flow from operating activities:    
Net income (loss) $ 124,286 $ (3,468,961)
Adjustment to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 343,815 1,004,565
Fair value of vested stock options 110,406 84,438
Fair value of warrants issued for services, net of adjustment 0 (237,126)
Fair value of warrant extensions 0 264,714
Gain on sale of fixed assets (6,879) 0
Changes in operating assets and liabilities:    
Accounts receivable (2,773,262) (785,273)
Inventory 11,718 167,985
Due from factor (63,604) 272,186
Prepaid expenses (590,644) 61,394
Prepaid royalties 13,779 786,449
Deposits and other assets (2,913) 60,706
Accounts payable and accrued expenses 3,677,225 3,492,110
Deferred revenue and other current liabilities 257,474 94,000
Net cash provided by operating activities 1,101,401 1,797,187
Cash flow from investing activities:    
Purchase of property and equipment (61,810) (44,607)
Purchase of intangible assets 0 (161,140)
Proceeds from sale of fixed asset 16,357 0
Net cash used in investing activities (45,453) (205,747)
Cash flow from financing activities:    
Payments to factor (8,860) 0
Payment of notes payable (28,263) (42,249)
Payment of capital lease obligation (262,845) (484,835)
Payment of related parties 0 (67,383)
Repayments under line of credit (900,000) (661,769)
Net cash used in financing activities (1,199,968) (1,256,236)
Effect of exchange rate changes (108,673) 138,197
Net increase (decrease) in cash and cash equivalents (252,693) 473,401
Cash and cash equivalents, beginning of period 3,150,978 2,868,260
Cash and cash equivalents, end of period 2,898,285 3,341,661
Supplemental disclosures of cash flow information:    
Cash paid for income taxes 1,681 19,629
Cash paid for interest 59,560 123,014
Supplemental disclosures of non-cash investing and financing activities:    
Acquisition of customer list through issuance of common shares $ 154,908 $ 0